![NATA](https://nata.com.au/files/2021/02/nata.png)
National Association of Testing Authorities, Australia
Scope of Accreditation
UQ Centre for Clinical Diagnostics - The University of Queensland Centre for Clinical Research
Site
UQ Centre for Clinical Research
Accreditation No.
19121
Site No.
21582
Date of Accreditation
03 Jul 2013
Address
Level 7, Building 71/918, Royal Brisbane and Women's Hospital Campus, Herston Road
Royal Brisbane Hospital, QLD 4029
Australia
Contact
Availability
Services conditionally available to external clients
Scope of Accreditation
ISO/IEC 17025 (2017)
Healthcare, Pharmaceutical and Media Products
Service | Product | Determinant | Technique |
---|---|---|---|
Analysis in support of clinical trials and/or pre-clinical studies | Animal biological samples; Human biological samples | Impact of pharmaceuticals and biological agents on the diagnosis and treatment outcomes for human disease and disorders | Cell culture; Enzyme linked immunosorbent assay (ELISA); Exosome isolation; LC-MS; LC-MS-MS; Multiplex bead array assays; Nanoparticle tracking analysis; Real time live cell monitoring and imaging; Western blot |
Pharmacokinetic data including sampling time, drug, concentration and dosing information | Pharmacokinetic (PK) parameters | Non-compartmental analysis | |
Analysis in support of research | Animal biological samples; Human biological samples; Samples isolated from primary cultured cells and tissues | Impact of pharmaceuticals and biological agents on the diagnosis and treatment outcomes for human disease and disorders | Cell culture; Enzyme linked immunosorbent assay (ELISA); Exosome isolation; LC-MS; LC-MS-MS; Multiplex bead array assays; Nanoparticle tracking analysis; Real time live cell monitoring and imaging; Western blot |
Pharmacokinetic data including sampling time, drug, concentration and dosing information | Pharmacokinetic (PK) parameters | Non-compartmental analysis | |
Analysis in support of the development and/or optimisation of new assays, devices or techniques | Animal biological samples; Human biological samples; Samples isolated from primary cultured cells and tissues | Impact of pharmaceuticals and biological agents on the diagnosis and treatment outcomes for human disease and disorders | Cell culture; Enzyme linked immunosorbent assay (ELISA); Exosome isolation; LC-MS; LC-MS-MS; Multiplex bead array assays; Nanoparticle tracking analysis; Real time live cell monitoring and imaging; Western blot |
The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.
Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.
Accreditation No.
19121
Site No.
21582
Print date
01 Sep 2024